IMMUNEONCO-B (01541): The approval for full circulation of H shares is granted by the Hong Kong Stock Exchange for listing.
Yiming Angke-B (01541) announces, regarding the company's plan to participate in the H-share full circulation plan, the company has submitted to the Listing Committee of the Stock Exchange...
IMMUNEONCO-B(01541) announced that the company intends to participate in the H-share full circulation plan. The company has applied to the Listing Committee of the Hong Kong Stock Exchange for approval to list and trade 14,114,006 H shares on the main board of the Hong Kong Stock Exchange. The company announced that the Hong Kong Stock Exchange has granted permission to list on April 24, 2025.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
